Kaihong Mi
Expertise in
14
conditions

Dr. Kaihong Mi

Hematology Oncology
UPMC Hillman Cancer Center - Mechanicsburg
2020 Technology Parkway, Suite 3200, 
Mechanicsburg, PA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
14
conditions
UPMC Hillman Cancer Center - Mechanicsburg
2020 Technology Parkway, Suite 3200, 
Mechanicsburg, PA 

Overview

Kaihong Mi, MD, PhD, specializes in hematology oncology and is certified in medical oncology, hematology and internal medicine by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center in Harrisburg and is affiliated with UPMC Harrisburg, UPMC Hanover, UPMC Lititz, UPMC Memorial, UPMC Community Osteopathic, UPMC West Shore and UPMC Carlisle. She completed her residency program at Easton Hospital, medical school at Zhejiang University and fellowship program at Cleveland Clinic Education Foundation.

Dr. Mi is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Metastatic Pleural Tumor, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Small Cell Lung Cancer (SCLC).

She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 2 clinical trials. Dr. Mi is currently accepting new patients.

Specialties

Hematology Oncology

Licenses

Internal Medicine in PA

Fellowships

Cleveland Clinic Education Foundation

Hospital Affiliations

Upmc Carlisle
Upmc Pinnacle Hospitals

Languages Spoken

English
Mandarin

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UPMC Hillman Cancer Center - Mechanicsburg
2020 Technology Parkway, Suite 3200, Mechanicsburg, PA 17050
Other Locations
UPMC Hillman Cancer Center at UPMC Community Osteopathic
4300 Londonderry Road, Suite 302, Harrisburg, PA 17109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2026
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
View 1 Less Clinical Trial

4 Total Publications

Concurrent Breast Carcinoma and Follicular Lymphoma: A Case Series.
Concurrent Breast Carcinoma and Follicular Lymphoma: A Case Series.
Journal: The American journal of case reports
Published: November 12, 2021
Similar Doctors
Expertise in
45
conditions
Dr. Dan Sotirescu
Hematology Oncology | Oncology
Expertise in
45
conditions
Dr. Dan Sotirescu
Hematology Oncology | Oncology
Referral may be required
Before you request

Cancer Care Associates Of York

25 Monument Road, Suite 294, 
York, PA 
 (27.7 miles away)
717-741-9229
Languages Spoken:
English, French, Romanian
See accepted insurances
Accepting New Patients
Offers Telehealth

Dan Sotirescu is a Hematologist Oncology specialist and an Oncologist practicing medicine in York, Pennsylvania. Dr. Sotirescu is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Severe Congenital Neutropenia, Familial Colorectal Cancer, Lung Cancer, and Bone Marrow Aspiration. Dr. Sotirescu is board certified in American Board Of Internal Medicine, Hematology - 2003 and American Board Of Internal Medicine, Medical Oncology - 2001. Dr. Sotirescu is currently accepting new patients.

Expertise in
32
conditions
Dr. Lily H. Shah
Hematology Oncology
Expertise in
32
conditions
Dr. Lily H. Shah
Hematology Oncology
Referral may be required
Before you request

Penn State Health Medical Group Andrews Patel Hematology/Oncology

3912 Trindle Road, 
Camp Hill, PA 
 (4.3 miles away)
717-761-8740
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lily Shah is a Hematologist Oncology provider practicing medicine in Camp Hill, Pennsylvania. Dr. Shah is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Anemia, and Childhood Iron Deficiency Anemia. Dr. Shah is currently accepting new patients.

Expertise in
57
conditions
Dr. Joyce J. Huang
Hematology Oncology
Expertise in
57
conditions
Dr. Joyce J. Huang
Hematology Oncology
Referral may be required
Before you request

Cancer Care Associates Of York

25 Monument Road, Suite 294, 
York, PA 
 (27.9 miles away)
717-741-9229
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joyce J. Huang, MD, specializes in hematology oncology. She is affiliated with UPMC Memorial. Dr. Huang completed her fellowship at Roswell Park Cancer Institute, residency at Saint Barnabas Medical Center and medical degree at Nantong Medical University. Dr. Huang is highly rated in 57 conditions, according to our data. Her clinical expertise encompasses Severe Congenital Neutropenia, Paget Disease of the Breast, Multiple Myeloma, and Agranulocytosis. Dr. Huang is currently accepting new patients.

Frequently Asked Questions about Dr. Kaihong Mi

How do I make an appointment with Dr. Kaihong Mi?

You can book an appointment with Dr. Kaihong Mi by calling their office at 717-988-1428. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kaihong Mi a top-rated expert for Metastatic Pleural Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kaihong Mi is classified as an Distinguished expert for Metastatic Pleural Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kaihong Mi specialize in?

While Dr. Kaihong Mi is a Hematology Oncology, they have specific expertise in Metastatic Pleural Tumor, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Kaihong Mi participate in research or clinical trials?

Yes. Dr. Kaihong Mi has published 4 articles and abstracts on conditions like Metastatic Pleural Tumor. You can view a list of Dr. Kaihong Mi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kaihong Mi accept my insurance?

Dr. Kaihong Mi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 717-988-1428 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mi's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 72 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile